Dorsey Wright & Associates Novo Nordisk A S Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

A detailed history of Dorsey Wright & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Dorsey Wright & Associates holds 62,128 shares of NVO stock, worth $5.43 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
62,128
Previous 54,585 13.82%
Holding current value
$5.43 Million
Previous $7.79 Million 5.06%
% of portfolio
1.81%
Previous 2.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$119.07 - $145.42 $898,145 - $1.1 Million
7,543 Added 13.82%
62,128 $7.4 Million
Q2 2024

Aug 15, 2024
SELL
$122.71 - $146.91 $227,013 - $271,783
-1,850 Reduced 3.28%
54,585 $7.79 Million
Q1 2024

May 08, 2024
SELL
$102.11 - $135.92 $340,434 - $453,157
-3,334 Reduced 5.58%
56,435 $7.25 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $407,650 - $489,709
-4,644 Reduced 7.21%
59,769 $6.18 Million
Q3 2023

Nov 07, 2023
BUY
$90.94 - $199.54 $2.74 Million - $6.01 Million
30,137 Added 87.92%
64,413 $5.86 Million
Q2 2023

Jul 26, 2023
SELL
$155.98 - $172.65 $537,195 - $594,606
-3,444 Reduced 9.13%
34,276 $5.55 Million
Q1 2023

Apr 19, 2023
SELL
$132.34 - $159.14 $332,438 - $399,759
-2,512 Reduced 6.24%
37,720 $6 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $458,808 - $605,466
-4,474 Reduced 10.01%
40,232 $5.44 Million
Q2 2022

Jul 20, 2022
SELL
$103.24 - $121.81 $549,030 - $647,785
-5,318 Reduced 10.63%
44,706 $4.98 Million
Q1 2022

Apr 27, 2022
SELL
$93.1 - $112.54 $139,929 - $169,147
-1,503 Reduced 2.92%
50,024 $5.56 Million
Q4 2021

Jan 27, 2022
BUY
$95.88 - $117.08 $97,126 - $118,602
1,013 Added 2.01%
51,527 $5.77 Million
Q3 2021

Oct 26, 2021
BUY
$84.42 - $106.62 $4.26 Million - $5.39 Million
50,514 New
50,514 $4.85 Million
Q1 2021

Apr 27, 2021
SELL
$67.06 - $75.82 $3.98 Million - $4.5 Million
-59,319 Closed
0 $0
Q4 2020

Jan 28, 2021
SELL
$63.89 - $73.8 $52,453 - $60,589
-821 Reduced 1.37%
59,319 $4.14 Million
Q3 2020

Oct 28, 2020
BUY
$63.69 - $70.22 $55,155 - $60,810
866 Added 1.46%
60,140 $4.18 Million
Q2 2020

Jul 23, 2020
SELL
$58.54 - $67.94 $284,797 - $330,528
-4,865 Reduced 7.59%
59,274 $3.89 Million
Q1 2020

Apr 20, 2020
BUY
$49.46 - $64.78 $887,262 - $1.16 Million
17,939 Added 38.83%
64,139 $3.86 Million
Q4 2019

Jan 31, 2020
BUY
$49.86 - $58.26 $2.3 Million - $2.69 Million
46,200 New
46,200 $2.67 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email